ScienceDex / Researcher record
Hava, David L
- Metera Pharmaceuticals, Inc. (no department on record)
From the FY2020 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 10% Funded
- Early Career
NIH Funding · FY2020
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2020): $1.5M in linked award amounts across 1 award record · Award-linked rank #1444.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2020 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2020 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2020 award records by amount
NIH award records listing Hava, David L as a PI. Multi-PI records show the full award amount for context.
- 1R44HL151067-01R44Contact PIInhaled IRK inhibitors as a novel therapeutic for IPF$1.5Maward amount
Award organization
Organizations that administered FY2020 awards listing Hava, David L as a PI.
FY2020 award administered by Metera Pharmaceuticals, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2020First NIH AwardMetera Pharmaceuticals, Inc.
- 2020$500K Cumulative Funding
- 2020$1M Cumulative Funding
- 2020Entered Top 50% NationallyRanked #1444
- 2020Entered Top 25% NationallyRanked #1444
- 2020Entered Top 10% NationallyRanked #1444